Intermittent Pneumatic Compression Device Sales Pitch Deck That Starts Clean

Why Now, and What Urgent Problem Are You Solving?

The market timing is driven by the urgent need for cost-effective DVT prophylaxis and the shift toward post-acute care at home. Hospitals need reliable, easy-to-use devices to reduce venous thromboembolism (VTE) risk, especially as patients are discharged sooner, making the transition from hospital-grade to home-use compression therapy critical.

Current Market Drivers

• Increasing surgical volumes drive VTE risk.
• Pressure on hospitals to lower readmission penalties.
• Growing demand for home-use medical equipment.

What Do You Do-and Why Will You Win?

We provide a comprehensive DVT prevention solution, offering both advanced hospital pumps and high-volume disposable garments. Our winning edge lies in our dual-product strategy, intellectual property protection, and regulatory clearance (FDA 510(k)), allowing us to capture both high-margin capital sales and recurring revenue from consumables.

Product Mix and Scale

• Forecast 1,200 Pro Pumps sold in 2026.
• Project 25,000 Standard Leg Sleeves sold in 2026.
• Focus on recurring revenue from disposable sleeves.

Who Buys, and How Big Is the Opportunity?

The primary buyers are hospital procurement departments, Group Purchasing Organizations (GPOs), and durable medical equipment (DME) providers, targeting orthopedic and vascular surgery segments. The opportunity is substantial: our financial model shows revenue scaling from $6.04 million in Year 1 to $47.27 million by Year 5, with EBITDA growing from $3.06 million to $29.95 million over the same period.

Scaling the Financials

• Targeting hospitals via GPOs and direct sales.
• Year 1 EBITDA margin is strong at 50.6%.
• Breakeven achieved quickly in January 2026.

This Intermittent Pneumatic Compression device (IPC) sales pitch deck is built on the canonical 8-slide format that institutional investors expect. Following this proven structure-covering Problem, Solution, Market, and Financials-defintely enhances your credibility. It saves you the headache of organizing complex medical technology data, ensuring your presentation is logical, tight, and easy for any potential partner or hospital procurement team to trust.

Aligns with professional investor standards

Speeds up preparation and review time

Focuses on core financial viability

The entire medical device sales template is 100 percent editable in Microsoft PowerPoint and Google Slides. You need to adapt the content, design, and branding to match your specific FDA-cleared equipment and target market, whether B2B hospital sales or direct-to-patient home-use IPC devices. This flexibility means you can tailor the deck without needing expensive design consultants or technical skills.

Customize text, colors, and images easily

Works in PowerPoint or Google Slides

Adapt content for specific audiences

The template guides you to craft a powerful narrative that immediately clarifies your value proposition. By focusing on the critical need for effective DVT prevention sales presentation materials, you clearly define the market pain point-reducing post-operative prophylaxis complications-and showcase how your vascular compression device is the unique solution. This format hooks the audience fast.

Clearly defines market pain point

Highlights unique device solution

Engages investors from the start

To build investor confidence, you must prove the scale of the opportunity. This deck includes structured slides for demonstrating market demand, including Total Addressable Market (TAM), Serviceable Available Market (SAM), and Serviceable Obtainable Market (SOM) formats. Showcasing industry trends and growth potential validates that your IPC sales strategy is targeting a massive, growing sector.

Quantifies opportunity (TAM/SAM/SOM)

Validates scale for medical technology

Builds strong investor confidence

Investors need to see exactly how you generate revenue. This section makes it easy to communicate your financial logic. You are selling both high-value capital equipment (pumps) and high-volume disposable garments (sleeves), which is a strong model. Clear revenue streams, pricing tiers, and unit economics reassure investors of your company's scalability and viability in the competitive medical technology space.

Shows clear revenue streams

Maps pricing and unit economics

Proves business scalability

No medical device operates in a vacuum. The template includes a dedicated slide to compare key competitors, helping you position your advantages clearly. By highlighting your differentiators-perhaps superior battery life, better user interface, or lower cost-per-use-you prove why your sequential compression device presentation is more compelling than existing post-operative prophylaxis options.

Compares key market rivals

Highlights defensible advantages

Proves market positioning

When seeking capital, clarity is paramount. This structure simplifies how you present your fundraising needs, ensuring you state the round size and instrument (equity, convertible note) clearly. Pre-built structures help clarify capital usage-such as R&D lab equipment or manufacturing tooling-and align with investor expectations, showing a disciplined, actionable plan for the funds.

Clarifies capital needs and usage

Aligns with investor expectations

Shows disciplined spending plan

Founders should focus on sales, not slide design. This ready-to-use template saves you hours of work and cuts thousands in potential consulting fees. It delivers an instantly professional, high-quality presentation that is specifically tailored for medical device sales, allowing you to move faster from prototype to hospital procurement presentation.

Saves hours of design work

Reduces consulting fees

Delivers instant professionalism

Whether you are raising a pre-seed round for initial FDA 510(k) clearance or a Series A to scale manufacturing, this pitch deck is built to suit your phase. Its modular structure supports pre-seed, seed, and Series A fundraising efforts, adapting to each stage's specific messaging needs, from proving clinical efficacy to showing rapid revenue growth.

Supports pre-seed through Series A

Modular structure adapts easily

Scales with your business needs